Information Provided By:
Fly News Breaks for March 4, 2020
Mar 4, 2020 | 17:25 EDT
Citi analyst Joanne Wuensch initiated coverage of Medtronic with a Buy rating and $124 price target. The analyst is positive on the company's "robust" pipeline with its Hugo Robotic Assisted Surgery technology set to perform its first-in-human operation early next year as well as its Evolut Pro+ TAVR system and Micra AV transcatheter pacing system. Wuensch adds that she will look for greater accountability and increased tuck-in M&A under the leadership of Medtronic's new CEO Geoff Martha.
News For MDT From the Last 2 Days
Apr 20, 2021 | 10:30 EDT
Medtronic is recalling the Bio-Console 560 Extracorporeal Blood Pumping Console due to reports of electrical failure causing the device to stop, the FDA said in a statement. Other issues observed by users include the interface going blank, smoke coming from the device and a burning odor during use, it added. There have been nine complaints reported about the device issue, including three injuries. No deaths have been reported. The FDA has identified this as a Class I recall, the most serious type of recall. Reference Link
Apr 19, 2021 | 09:24 EDT
73rd Annual Virtual Meeting of AAN will be held on April 17-22. Webcast Link